BDBM499396 4-((3-(6-(cyclopropylmethoxy)- 5-methylpyridin-3-yl)-6- fluorophenoxy)methyl)-N- (methylsulfonyl)benzamide::US11020381, Example 92

SMILES Cc1cc(cnc1OCC1CC1)-c1cc(F)cc(OCc2ccc(cc2)C(=O)NS(C)(=O)=O)c1

InChI Key InChIKey=XLSNYMJYZJMGJU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 499396   

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandPNGBDBM499396(4-((3-(6-(cyclopropylmethoxy)- 5-methylpyridin-3-y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent